Stocks
Sino Biopharmaceutical Limited (SBMFF) Debt/EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | -0.18 | -0.44 | -0.22 | -0.79 | -0.88 | -1.37 | |||
| Changes by years, y/y, % | -53% | +137% | -50% | +258% | +12% | +17.6% | |||
Sino Biopharmaceutical Limited. Debt/EBITDA
Sino Biopharmaceutical Limited. Debt/EBITDA, changes, %
Sino Biopharmaceutical Limited (SBMFF) Debt/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| Debt/EBITDA | -1.29 | -1.03 | -0.95 | -1.18 | -1.00 | -1.37 | ||
| Changes by years, y/y, % | +179% | +47% | +21% | -8% | -22% | |||
| Changes by quarters, q/q, % | +0% | -20% | -8% | +24% | -15% | |||
